Integra Lifesciences Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$21Mgeneral payments (2019-2025)
$2.4Mresearch payments (2019-2025)
37,726clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $4.5M
2020 $3.7M
2021 $2.0M
2022 $2.4M
2023 $2.3M
2024 $2.9M
2025 $3.1M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Plastic Surgery $3.5M
Orthopaedic Surgery $2.9M
Foot & Ankle Surgery $2.7M
Surgery $1.8M
Hand Surgery $1.6M
Plastic and Reconstructive Surgery $1.5M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
James Brodsky Dallas, TX Orthopaedic Surgery $584,503.90
Matthew Ramsey King of Prussia, PA Orthopaedic Surgery $540,053.17
Ian Valerio Columbus, OH Plastic Surgery $507,665.46
Michael Bauer Castle Rock, CO Blood Banking & Transfusion Medicine $450,500.00
William Geissler Jackson, MS Hand Surgery $448,666.61
David Adelman Houston, TX Plastic Surgery $386,966.31
John Fischer Philadelphia, PA Plastic Surgery $358,905.78
Christopher Hyer Worthington, OH Foot & Ankle Surgery $337,331.84
Selene Parekh Bensalem, PA Orthopaedic Surgery $317,645.53
Ryan Garcia Charlotte, NC Hand Surgery $312,023.11

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.